Impax resolves FDA warning letter; Recipharm to manufacture Parkinson's drug for LobSor;

> Impax Laboratories ($IPXL) reports that it has resolved its FDA warning letter for a plant in Hayward, CA. Release

> Recipharm has reached an agreement to manufacture a proprietary treatment for advanced Parkinson's disease for Sweden-based LobSor Pharmaceuticals. Release

> The EPA has proposed a rule that would make it easier for healthcare providers to dispose of pharmaceutical waste. Blog post

> Kamani Oil Industries announced today that they have become the first Indian vegetable oil industry to get an FDA drug license for manufacture of pharmaceutical-grade oils and fats. Report